, , , , , , , , , , , , , , , ,

JUVÉDERM® products offer proven success


JUVÉDERM®  is not only one of the top selling dermal fillers in the USA it is also the first and only non-surgical hyaluronic acid (HA) filler that is FDA-approved to smooth out lines and restore volume.


Why Clients Love It?

Smoothing lines and adding volume to the cheeks is simple with JUVÉDERM®. The procedure is non-surgical and can be performed during a routine appointment. Formulated using proprietary HYLACROSS™ technology, its cutting-edge formulation offers proven results with less discomfort because of the added Lidocain. There is minimal downtime if at all; with an experienced hand, bruising can be kept to the minimum.


The sophisticated JUVÉDERM® Range

Offering instant, natural-looking results the range includes:

  1. JUVÉDERM® XC is formulated to instantly smooth moderate to severe wrinkles around the nose and mouth for up to one year under optimum conditions.
  2. JUVÉDERM® Ultra XC is specifically used for lip augmentation and is injected into the lips and perioral area of the lips.
  3. JUVÉDERM VOLUMA® XC works to restore volume to your cheek area to correct age-related volume loss. It can provide contour and a subtle lift for up to two years.


How does JUVÉDERM® work?

Each product in the JUVÉDERM® range is formulated for use on a specific area to achieve best results. The difference lies in the size of the molecules and the depth at which they are injected within the layers of skin. For cheek augmentation, big particles are injected deeper into dermis to match tissue in the area resulting in a lift.  While small particles injected more superficially to smooth out fine lines and wrinkles, this also makes it less visible under the skin.


Finding the right fit

JUVÉDERM® is my product of choice because it not only offers best results, it is FDA approved for safety. To find out if you are a candidate for JUVÉDERM®, simply make an appointment and together we can discuss your aesthetic rejuvenation goals.

Connect with Dr Martina van der Mescht,

visit the Facebook / Twitter page